Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Stay in your lane: We don’t need rich white actresses’ comments on sex work

A group of rich and famous white actress/feminists who have probably never in their life traded sex or experienced criminalization have added their rich and famous names onto a letter condemning a proposal from Amnesty International to adopt a position to support the decriminalization of sex work.

Published
5 hours ago
From
Feministing.com
Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme

Interferon-free treatment using daclatasvir (Daklinza) and sofosbuvir (Sovaldi), with or without ribavirin, was well-tolerated and produced sustained virological response rates of 95-100% for people with HIV and

Published
10 hours ago
By
Liz Highleyman
PrEP, Earlier ART, and Better HIV Care in the Updated National HIV/AIDS Strategy

Today, the White House Office of National AIDS Policy (ONAP) announced an update to the National HIV/AIDS Strategy that will guide our nation’s efforts to reduce new infections, improve HIV … Read More →

Published
18 hours ago
From
BETA blog
NICE issues appraisal consultation documents for three new hepatitis C therapies

The National Institute for Clinical Excellence (NICE) has today issued appraisal consultation documents for three new hepatitis C therapies; ledipasvir-sofosbuvir (Harvoni), daclatasvir (Daklinza, and ombitasvir/paritaprevir/ritonavir (with or without dasabuvir).

Published
30 July 2015
From
Hepatitis C Trust
GSK flags up pipeline as HIV drugs help it beat profit forecasts

GlaxoSmithKline moved to reclaim its prowess as a research powerhouse on Wednesday by flagging up dozens of new drugs and vaccines in development, as demand for new HIV medicines helped it beat quarterly profit forecasts.

Published
30 July 2015
From
Reuters
Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge

Gilead Sciences Inc., maker of the hepatitis C drugs Sovaldi and Harvoni, posted second-quarter profit that topped analysts’ estimates as revenue surged. Gilead raised its sales forecast for the year.

Published
30 July 2015
From
Bloomberg
Statement of Support for Amnesty International

The Global Network of Sex Work Projects (NSWP) would like to take this opportunity to express our support for Amnesty International’s Resolution and draft policy calling for the decriminalisation of sex work, tabled for adoption at the International Council Meeting, 6 - 11th August 2015.

Published
30 July 2015
From
Global Network of Sex Work Projects
Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies

Three different interferon-free regimens – sofosbuvir/ledipasvir, AbbVie's 3D regimen and grazoprevir/elbasvir – were well-tolerated and cured more than 90% of participants with HIV and HCV co-infection in

Published
29 July 2015
By
Liz Highleyman
Intensification of antiretroviral therapy reduces risk of late-term mother-to-child HIV transmission

Maternal and infant antiretroviral therapy (ART) intensification is very effective in preventing HIV transmission during labour and birth in pregnant women with HIV in Thailand who present late

Published
29 July 2015
By
Carole Leach-Lemens
Merck Targets Toughest Cases to Gain Hepatitis C Foothold

Merck & Co. plans to target hard-to-treat hepatitis C patients with its cure for the liver ailment rather than compete for market share by drastically undercutting the price of Gilead Sciences Inc.'s $1,000-a-day treatment.

Published
29 July 2015
From
Bloomberg
← First12345...1953Next →

Filter by country